RA Capital Management, L.P. 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 6,381,144 6.400% |
1,167,483 (+22.39%) |
Filing |
| 2024-04-04 7:04 pm Purchase |
2024-03-25 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 5,213,661 6.400% |
5,213,661 (New Position) |
Filing |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 0 0.000% |
-2,805,045 (Position Closed) |
Filing |
| 2022-02-14 4:11 pm Unchanged |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 2,805,045 5.400% |
0 (Unchanged) |
Filing |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 2,805,045 6.200% |
2,805,045 (New Position) |
Filing |